IFP Advisors Inc raised its holdings in HCA Healthcare, Inc. (NYSE:HCA – Free Report) by 23.2% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 9,444 shares of the company’s stock after acquiring an additional 1,777 shares during the quarter. IFP Advisors Inc’s holdings in HCA Healthcare were worth $2,835,000 at the end of the most recent quarter.
Several other hedge funds also recently modified their holdings of the stock. Integrated Advisors Network LLC grew its holdings in HCA Healthcare by 0.6% in the third quarter. Integrated Advisors Network LLC now owns 5,132 shares of the company’s stock worth $2,086,000 after purchasing an additional 31 shares during the period. First Horizon Advisors Inc. increased its position in HCA Healthcare by 2.4% in the 3rd quarter. First Horizon Advisors Inc. now owns 1,532 shares of the company’s stock valued at $623,000 after buying an additional 36 shares in the last quarter. Mediolanum International Funds Ltd boosted its holdings in HCA Healthcare by 0.3% in the fourth quarter. Mediolanum International Funds Ltd now owns 10,592 shares of the company’s stock worth $3,153,000 after acquiring an additional 36 shares in the last quarter. Hartford Funds Management Co LLC increased its holdings in shares of HCA Healthcare by 1.6% during the third quarter. Hartford Funds Management Co LLC now owns 2,469 shares of the company’s stock valued at $1,003,000 after acquiring an additional 39 shares in the last quarter. Finally, Prairie Wealth Advisors Inc. lifted its holdings in shares of HCA Healthcare by 6.1% in the 4th quarter. Prairie Wealth Advisors Inc. now owns 700 shares of the company’s stock worth $210,000 after purchasing an additional 40 shares in the last quarter. Institutional investors own 62.73% of the company’s stock.
HCA Healthcare Price Performance
HCA Healthcare stock opened at $319.33 on Tuesday. The business has a 50-day simple moving average of $313.72 and a 200 day simple moving average of $350.53. HCA Healthcare, Inc. has a 52 week low of $289.98 and a 52 week high of $417.14. The stock has a market cap of $79.30 billion, a price-to-earnings ratio of 14.53, a PEG ratio of 1.10 and a beta of 1.64. The company has a quick ratio of 0.97, a current ratio of 1.08 and a debt-to-equity ratio of 69.07.
HCA Healthcare Increases Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Monday, March 31st. Stockholders of record on Monday, March 17th will be given a dividend of $0.72 per share. The ex-dividend date is Monday, March 17th. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.66. This represents a $2.88 annualized dividend and a dividend yield of 0.90%. HCA Healthcare’s dividend payout ratio is 13.11%.
Wall Street Analysts Forecast Growth
A number of research analysts have weighed in on the stock. Oppenheimer raised their price objective on shares of HCA Healthcare from $390.00 to $400.00 and gave the company an “outperform” rating in a research note on Monday, October 28th. StockNews.com lowered HCA Healthcare from a “strong-buy” rating to a “buy” rating in a research report on Monday, November 4th. Cantor Fitzgerald reiterated an “overweight” rating and issued a $405.00 target price on shares of HCA Healthcare in a report on Monday, January 27th. Barclays reduced their price objective on shares of HCA Healthcare from $392.00 to $366.00 and set an “overweight” rating for the company in a research report on Monday, January 27th. Finally, Raymond James downgraded HCA Healthcare from an “outperform” rating to a “market perform” rating in a research note on Friday, November 22nd. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have issued a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $385.67.
Check Out Our Latest Research Report on HCA Healthcare
Insider Buying and Selling
In other HCA Healthcare news, SVP Jennifer Berres sold 9,533 shares of HCA Healthcare stock in a transaction that occurred on Friday, February 14th. The shares were sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the transaction, the senior vice president now directly owns 15,412 shares of the company’s stock, valued at approximately $4,971,757.08. This trade represents a 38.22 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 1.60% of the stock is currently owned by corporate insiders.
HCA Healthcare Profile
HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.
Read More
- Five stocks we like better than HCA Healthcare
- Insider Trading – What You Need to Know
- Finding Hidden Gems: Unconventional Penny Stock Investing
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Price Targets on NVIDIA Rise in Front of Earnings
- Following Congress Stock Trades
- Archer Aviation Stock Skids: Mistaking Progress for Bad News?
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA – Free Report).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.